Nares-Torices MÁ, Hernández-Pacheco JA, Estrada-Altamirano A, Mendoza-Calderón A, Cervera-Buenfil CI, Villalva-Hernández LD, Hernández-Muñoz VA

Language: Spanish
References: 22
Page: 96-105
PDF size: 117.27 Kb.

ABSTRACT

Introduction: Systemic lupus erythematosus (SLE) complicates one of every 1,000 pregnancies in Latin American population, 10 to 25% of, patients with systemic rheumatic disease, require hospitalization while attend to emergency room, and 30% of these require intensive care treatment. The death incidence in SLE patients in intensive care units can be up to 79%. Objective: Describe the clinical course and prognosis of pregnant women who were diagnosed with active systemic lupus erythematosus (ASLE), admitted to an intensive care unit. Material and methods: Between January 2005 and December 2009 at the intensive care unit of the Instituto Nacional de Perinatología (INPer), 23 pregnant patients diagnosed and treated with ASLE, were studied to determine, the clinical course and prognosis. Results: High frequencies in intrauterine growth restriction (39%), preterm delivery (80%), fetal death (13%), severe preeclampsia (30.4%) and maternal death (17%) were seen. Also found significant differences in proteinuria, uric acid, IUGR and fetal death in those patients who had preterm birth and those who had not. Conclusions: Active systemic lupus erythematosus associated with pregnancy, has high frequency of adverse perinatal outcomes, like premature delivery and severe preeclampsia. So it has to be considered, that this type of patients must be controlled and treated in the appropriate facility by an interdisciplinary professional team, with the aim of consider diminishing those complications.

REFERENCES

1. Mintz G, Niz J, Gutiérrez G, García-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732-9.

2. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus 2008; 17: 416-20.

3. Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989; 32: 665-70.

4. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-45.

5. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003; 2: 119-25.

6. Whitelaw DA, Gopal R, Freeman V. Survival of patients with SLE admitted to an intensive care unit- a retrospective study. Clin Rheumatol 2005; 24: 223.

7. Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY et al. Outcome and prognostic factor in critically ill patients with systemic lupus erythematosus: retrospective study. Crit Care 2005; 9: R177-R83.

8. Ansell SM, Bedhesi S, Ruff B, Mahomed AG, Richards G, Mer M et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 1996; 24: 981-4.

9. Ranzani OT, Battaini LC, Moraes CE, Prada LF, Pinaffi JV, Giannini FP et al. Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythematosus and other systemic rheumatic diseases. Braz J Med Biol Res 2011; 44: 1184-93.

10. Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic VD. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus 2012; 21: 534-41.

11. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A Systemic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5: 2060-8.

12. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum 1995; 38: 1722-32.

13. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv 2011; 66: 639-53.

14. Wagner SJ, Craici I, Reed D, Norby S, Bailey K, Wiste HJ et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 2009; 18: 342-7.

15. Zonana-Nacach A, Yañez P, Jimenez-Balderas FJ, Camargo-Coronel A. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 2007; 16: 997-1000.

16. Ideguchi H, Ohno S, Uehara T, Ishiogatsubo Y. Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clinic Rev Allergy Immunol 2011. 011, DOI: 10.1007/s12016-011-8269-8Online First

17. Aggarwal N, Raveendran A, Suri V, Chopra S, Sikka P, Sharma A. Pregnancy outcome in systemic lupus erythematosus Asia’s largest single centre study. Arch Gynecol Obstet 2011; 284: 281-5.

18. Paula LG, da Costa BE, Poli-de- Figuereido, Antonello IC. Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension? Hypertens Pregnancy 2008; 27: 413-20.

19. Parrish M, Griffin M, Morris R, Darby M, Owens MY, Martin JN Jr. Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with sever/superimposed preeclampsia. J Matern Fetal Neonatal Med 2010; 23: 1451-5.

20. Namendys-Silva SA, Baltazar-Torres JA, Rivero-Sigarrosa E, Fonseca-Lazcano JA, Montiel-López L, Domínguez-Cherit G. Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus 2009; 18: 1252-8.

21. Donaldson LB, De Alvarez RR. Further observations on lupus erythematosus associated with pregnancy. Am J Obstet Gynecol 1962; 83: 1461-73.

22. Garsenstein M, Pollak V, Kars RM. Systemic lupus erythematosus and pregnancy. N Engl J Med 1962; 267: 165-9.